PTC Therapeutics, Inc. (PTCT) /
The revenue of PTC Therapeutics, Inc. over the past 10 years
Chart PTC Therapeutics, Inc.: revenue, fiscal 2016–2025 Open the chart →PTC Therapeutics, Inc. reported revenue of $1.73B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $82.7M — up 1993% over 9 years. Year over year, revenue rose 8 times and fell once. The largest one-year move was in fiscal 2017: up 135%, from $82.7M to $194.39M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $1.73B |
| 2024ended Dec 31, 2024 | $806.78M |
| 2023ended Dec 31, 2023 | $937.82M |
| 2022ended Dec 31, 2022 | $698.8M |
| 2021ended Dec 31, 2021 | $538.59M |
| 2020ended Dec 31, 2020 | $380.77M |
| 2019ended Dec 31, 2019 | $306.98M |
| 2018ended Dec 31, 2018 | $264.73M |
| 2017ended Dec 31, 2017 | $194.39M |
| 2016ended Dec 31, 2016 | $82.7M |
Fiscal years as PTC Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on PTC Therapeutics, Inc.
- The profitability of PTC Therapeutics, Inc.
- The cash flow of PTC Therapeutics, Inc.
- The debt of PTC Therapeutics, Inc.
- All of PTC Therapeutics, Inc.'s financials, charted
Companies of a similar size
- BROSDutch Bros Inc.
- ABCBAMERIS BANCORP
- MMSIMERIT MEDICAL SYSTEMS INC
- RDNTRadNet, Inc.
- GXOGXO Logistics, Inc.
Not investment advice. This page shows what PTC Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.